Parenting in adults with CAH (21-hydroxylase deficiency)
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at parenting in adults with congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency. It aims to understand how the condition affects family life so doctors can offer better support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a confirmed diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (a genetic condition).
- You must be willing to participate and have been informed about the study.
- You must speak French.
- You must be covered by French social security (or be eligible for it).
- You must not be under any legal protection, guardianship, or trusteeship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the long-term experiences of adults with classic congenital adrenal hyperplasia (CAH), a condition affecting hormone production. It aims to understand patient satisfaction and health outcomes over time.
This trial is creating a registry to track adult males with congenital adrenal hyperplasia (CAH) from 21-hydroxylase deficiency. It helps doctors learn more about the condition and how it changes over time.
This study aims to improve the transition from pediatric to adult care for young people with congenital adrenal hyperplasia (CAH). It will test a special transition program and may help make the shift to adult care smoother and more supported.
This study tests a new medication for children with classic congenital adrenal hyperplasia (CAH). It aims to see if the drug helps better control hormone levels and reduce the need for high doses of current steroid medicines.
This study tracks adults with congenital adrenal hyperplasia (a condition where the body can't make enough cortisol) who switch to a new form of hydrocortisone called modified-release. It looks at how well the medication works over time and its effects on daily life.
This study looks at fertility and sexual function in people with congenital adrenal hyperplasia (CAH), a condition affecting hormone production. It aims to understand how CAH impacts these areas.
Hear when a new CAH - 21-Hydroxylase Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.